Leqembi's day in front of FDA's experts
The FDA’s expert advisers on neurological drugs will discuss the application for traditional approval for Leqembi, the second treatment for Alzheimer’s disease to reach the market.
Source: politico.com
Stay updated with breaking news from Xavier Becerras. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA’s expert advisers on neurological drugs will discuss the application for traditional approval for Leqembi, the second treatment for Alzheimer’s disease to reach the market.